Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

17.72
Delayed Data
As of 4:00pm ET
 -0.02 / -0.11%
Today’s Change
8.18
Today|||52-Week Range
18.43
+79.35%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 18.00, with a high estimate of 33.00 and a low estimate of 8.00. The median estimate represents a +1.58% increase from the last price of 17.72.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.19
Sales
$102.6M
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 183.63%
 
 
 
 
 
 
Growthannually 84.45%
 
 
 
 
 
 

Sales

Growthquarterly 203.88%
 
 
 
 
 
 
Growthannually 76.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.